Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,894
Closed -$375K 286
2021
Q4
$375K Buy
4,894
+42
+0.9% +$3.7K 0.06% 230
2021
Q3
$466K Buy
4,852
+83
+2% +$9.06K 0.08% 201
2021
Q2
$509K Sell
4,769
-225
-5% -$22.1K 0.08% 199
2021
Q1
$447K Sell
4,994
-407
-8% -$44.8K 0.08% 217
2020
Q4
$542K Sell
5,401
-29
-0.5% -$2.16K 0.09% 193
2020
Q3
$265K Sell
5,430
-2,161
-28% -$104K 0.05% 255
2020
Q2
$310K Buy
7,591
+2,054
+37% +$59K 0.06% 245
2020
Q1
$85K Buy
+5,537
New +$116K 0.02% 412

Other funds holding CRNC

Arden Trust's CRNC Position: Q1 2022 in Review

Arden Trust sold out of Cerence (CRNC) in Q1 2022, closing a stake of 4,894 shares — an estimated $375K sold.

Arden Trust first reported a position in CRNC in Q1 2020 and held it in 8 quarters. The position peaked at $542K in Q4 2020. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

  • Arden Trust reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
  • Arden Trust sold 4,894 Cerence shares in Q1 2022, an estimated $375K.
  • Arden Trust first reported a position in Cerence in Q1 2020 and held it in 8 quarters.
  • Arden Trust's Cerence position peaked at $542K in Q4 2020.
  • 286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on Arden Trust's 13F filing for Q1 2022, filed 11 Apr 2022.